These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26779266)

  • 1. Development and evaluation of in situ nasal gel formulations of loratadine.
    Sherafudeen SP; Vasantha PV
    Res Pharm Sci; 2015; 10(6):466-76. PubMed ID: 26779266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics.
    Rana SJ; Zafar S; Shahzad A; Basit M; Mudassir J; Akhlaq M; Chohan TA; Arshad MS
    AAPS PharmSciTech; 2023 Nov; 24(8):242. PubMed ID: 38017208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra Nasal
    Paul A; Fathima KM; Nair SC
    Open Med Chem J; 2017; 11():222-244. PubMed ID: 29399211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts.
    Farid RM; Etman MA; Nada AH; Ebian Ael A
    AAPS PharmSciTech; 2013 Jun; 14(2):712-8. PubMed ID: 23516112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Cellulose Derivatives and Chitosan-Based Polymers to Investigate the Effect of Permeation Enhancers Added to In Situ Nasal Gels for the Controlled Release of Loratadine and Chlorpheniramine.
    Viswanadhan Vasantha P; Sherafudeen SP; Rahamathulla M; Mathew ST; Murali S; Alshehri S; Shakeel F; Alam P; Sirhan AY; Narayana Iyer BA
    Polymers (Basel); 2023 Feb; 15(5):. PubMed ID: 36904447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson's disease.
    Rao M; Agrawal DK; Shirsath C
    Drug Dev Ind Pharm; 2017 Jan; 43(1):142-150. PubMed ID: 27533244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation development and evaluation of nasal
    Boraste SV; Patil SB
    Drug Dev Ind Pharm; 2024 Jan; 50(1):11-22. PubMed ID: 38054848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases.
    Wang Y; Jiang S; Wang H; Bie H
    PLoS One; 2017; 12(12):e0189478. PubMed ID: 29240797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
    Galgatte UC; Kumbhar AB; Chaudhari PD
    Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
    Pawar P; Kashyap H; Malhotra S; Sindhu R
    Biomed Res Int; 2013; 2013():341218. PubMed ID: 23762839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
    Altuntaş E; Yener G
    AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermally triggered mucoadhesive in situ gel of loratadine: β-cyclodextrin complex for nasal delivery.
    Singh RM; Kumar A; Pathak K
    AAPS PharmSciTech; 2013 Mar; 14(1):412-24. PubMed ID: 23358934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine.
    Chelladurai S; Mishra M; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Nov; 56(11):1596-9. PubMed ID: 18981612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
    Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS
    Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of
    A S; Ahmed MG; Gowda Bh J
    J Oral Biol Craniofac Res; 2021; 11(2):269-276. PubMed ID: 33717865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
    Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on Poloxamer Based Mucoadhesive Insitu Ophthalmic Hydrogel of Moxifloxacin HCL.
    Shastri DH; Prajapati ST; Patel LD
    Curr Drug Deliv; 2010 Feb; ():. PubMed ID: 20158483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration.
    Salunke SR; Patil SB
    Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.